Skip to content

Teradata TDC Increase Decrease In Receivables

Increase Decrease In Receivables at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$13.1M-1,256%
V2X logo
V2XVVX
$90.7M+1,495%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$474K-96.6%
Schneider National logo
Schneider NationalSNDR
$59.9M+558%
Seaboard logo
SeaboardSEB
-$7M-600%
Terex logo
TerexTEX
$76M-43.3%

Other financials

Income statement

See full
Revenue$444.0M+6.2%
Gross profit$276.0M+11.3%
Operating income-$36.0M-155%
Net income$335.0M+661%
EPS (diluted)$3.47+671%

Balance sheet

See full
Cash & equivalents$816.0M+121%
Total debt$553.0M-6.0%
Total equity$557.0M+253%
Total assets$2.1B+22.3%

Cash flow

See full
Operating cash flow$401.0M+4,913%
CapEx$10.0M+900%
Free cash flow$391.0M+5,486%

Valuation

See full
Market cap$2.98B+12.2%

Profitability

See full
Gross margin60.1%+0.1pp
Operating margin6.1%-7.2pp
Net margin24.9%+16.8pp
FCF margin39.7%+24.1pp

Returns & leverage

See full
Return on equity117.8%-12.4pp
Debt / equity-2.7×
Current ratio1.3×+0.5×

Where this comes from

Reported directly by Teradata in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Teradata’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teradata's increase decrease in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teradata's increase decrease in receivables?
Teradata (TDC) reported increase decrease in receivables of $71M in Q1 2026.
How has Teradata's increase decrease in receivables changed year-over-year?
Teradata's increase decrease in receivables decreased by 2.7% year-over-year, from $73M to $71M.